Israeli pharmaceutical company BiolineRX Ltd. reports a successful pretrial of its BL-8020 drug, which is designed to orally treat Hepatitis C. The company has announced that due to the success of the pretrial, it will launch human trials during the first quarter of 2013.
Subscribe to NoCamels weekly newsletter and get our top stories
Facebook comments